 4. Subjects should be on stable doses of medications, which should remain unchanged until the DBS system is activated. After the DBS system is optimized during which time the overall medication dose may be reduced to avoid discomfort and complications such as dyskinesias the medication dose should remain unchanged, if possible, for the duration of the study. 